Calcium dysregulation, IP3 signaling, and Alzheimer's disease.
about
Synergy and Antagonism of Active Constituents of ADAPT-232 on Transcriptional Level of Metabolic Regulation of Isolated Neuroglial CellsCharacterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics AssessmentLong-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic miceMicroarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease.A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer diseaseER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology.Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation.Workflow and methods of high-content time-lapse analysis for quantifying intracellular calcium signals.Calcium ions promote formation of amyloid β-peptide (1-40) oligomers causally implicated in neuronal toxicity of Alzheimer's disease.Inositol trisphosphate receptor Ca2+ release channels in neurological diseases.Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons.NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice.Novel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors.General anesthetic isoflurane modulates inositol 1,4,5-trisphosphate receptor calcium channel opening.Endoplasmic reticulum Ca(2+) handling in excitable cells in health and diseaseDifferential subcellular Ca2+ signaling in a highly specialized subpopulation of astrocytes.Presenilin-like GxGD membrane proteases have dual roles as proteolytic enzymes and ion channels.Changes in the physiology of CA1 hippocampal pyramidal neurons in preplaque CRND8 mice.Analyzing and Quantifying the Gain-of-Function Enhancement of IP3 Receptor Gating by Familial Alzheimer's Disease-Causing Mutants in Presenilins.Lack of evidence for presenilins as endoplasmic reticulum Ca2+ leak channelsExpansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store.Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies.The pathogenesis of Alzheimers disease is it a lifelong "calciumopathy"?Alterations of some membrane transport proteins in Alzheimer's disease: role of amyloid beta-peptide.Impaired mitochondrial function due to familial Alzheimer's disease-causing presenilins mutants via Ca(2+) disruptions.Anesthesia, calcium homeostasis and Alzheimer's diseaseIntracellular calcium signalling in Alzheimer's diseaseSynapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease.K(Ca)2 and k(ca)3 channels in learning and memory processes, and neurodegeneration.Network-wide dysregulation of calcium homeostasis in Alzheimer's disease.Dantrolene, a treatment for Alzheimer disease?Amyloid-beta-(1-42) increases ryanodine receptor-3 expression and function in neurons of TgCRND8 mice.Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.The Role of Presenilin in Protein Trafficking and Degradation-Implications for Metal Homeostasis.Thapsigargin affects presenilin-2 but not presenilin-1 regulation in SK-N-BE cells.IP3 receptor mutations and brain diseases in human and rodents.Neuronal calcium wave propagation varies with changes in endoplasmic reticulum parameters: a computer model.Interactions between the amyloid precursor protein C-terminal domain and G proteins mediate calcium dysregulation and amyloid beta toxicity in Alzheimer's disease.Rosuvastatin and thapsigargin modulate γ-secretase gene expression and APP processing in a human neuroglioma model.Enhanced ROS generation mediated by Alzheimer's disease presenilin regulation of InsP3R Ca2+ signaling.
P2860
Q27500406-BE415B05-2D0C-4F37-83CC-C542A0991B0BQ28547909-7238B9CA-756A-4AB0-8A64-E4A71BD6FE3FQ30887483-8622C265-99C4-4544-A46B-D94E00AD1D53Q31023394-BDA2F37C-B6EA-4D24-9BCF-3308FF3FA7B2Q33297839-746D75DD-5663-47B3-8FCC-3BB58484E881Q33589732-A6E968C5-5C19-4466-AC5D-B51D06F1EE68Q33740340-E36793F1-8B77-4147-9847-47721705D85CQ33783339-41422D75-642F-4C84-BEB4-0CF82C7CB7ABQ33862507-039BFC4B-433D-440B-B1E2-1D439FD30E16Q33946097-725F9C04-D0AE-4D8A-AB93-3A1464481038Q33966472-6B4A5CA7-DAB1-4B12-BE2C-59ED89AB33D1Q34149384-52656D29-74A5-404D-9576-5E2D9781237FQ34571728-01C424EA-66A5-4095-8BE3-7309D9AB35B7Q34799569-D6419880-93DE-446F-BC86-C7E0032AFB60Q35122788-B8D2A3CC-78FF-4FFA-BC51-87EBADCD6910Q35137472-07DBF58E-C41C-4634-A54F-053F4E39CF7CQ35172983-E4CA1EFC-22E5-4B56-99FD-B75B03264A73Q35218837-37995B3B-6F80-410A-A757-5CB23D936485Q35800316-4BB0005A-836E-43DC-9E0A-7F7B53BF4201Q35879583-6DF7335A-D078-48D1-A648-31BBF0E9A75FQ35987301-B61CC7EA-D485-4C49-87AB-7133FCBE3B5DQ36466732-28ACDE9E-A12A-4A96-AAB6-41753A9903DFQ36954095-24462394-F798-4B77-A505-D0B451077FA2Q37030598-98BD818E-EA7D-48D8-8A77-53E8E4AA1BE1Q37383808-253EA3BD-5FC3-487E-AC3F-A04B9356D7F9Q37387269-E675BE73-FA8E-4FD0-9D0A-2CB2B82C1B7DQ37636324-491CCC7A-03B2-43E8-8D2D-A178B1B84A3DQ37875108-9CFC388F-2415-4D21-ABF4-300A3C56AC7BQ38018945-5CBD9C2D-4296-4F97-BAF9-168DB06FD70AQ38189691-A026CFCC-AF83-46C6-A3EF-2D903B2CDF30Q38304771-25252E94-67EF-4731-B30E-925C3D076987Q38308416-1B57196A-268F-4950-B46E-0B01ED55295DQ38890523-57C19EF5-5E00-4659-B211-DCC498210872Q38936434-558A4995-63B0-48EF-A881-41FCFAF350C7Q39040942-E6713C5C-3C07-424E-89C1-5ED3E10F691EQ39140608-30DB4769-681B-4BD4-B310-93D51138BABFQ39284251-2404DC73-29AD-49E3-8B69-49F1596A8802Q39618623-E21CC6C8-81A1-48E3-9762-C6D8874D7385Q39638936-B9929DA9-300F-4BFA-88E9-F52E2CED1451Q39668678-CA705509-E0D9-4F4C-AEE0-739D45E9997A
P2860
Calcium dysregulation, IP3 signaling, and Alzheimer's disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Calcium dysregulation, IP3 signaling, and Alzheimer's disease.
@ast
Calcium dysregulation, IP3 signaling, and Alzheimer's disease.
@en
Calcium dysregulation, IP3 signaling, and Alzheimer's disease.
@nl
type
label
Calcium dysregulation, IP3 signaling, and Alzheimer's disease.
@ast
Calcium dysregulation, IP3 signaling, and Alzheimer's disease.
@en
Calcium dysregulation, IP3 signaling, and Alzheimer's disease.
@nl
prefLabel
Calcium dysregulation, IP3 signaling, and Alzheimer's disease.
@ast
Calcium dysregulation, IP3 signaling, and Alzheimer's disease.
@en
Calcium dysregulation, IP3 signaling, and Alzheimer's disease.
@nl
P2860
P356
P1433
P1476
Calcium dysregulation, IP3 signaling, and Alzheimer's disease.
@en
P2093
Grace E Stutzmann
P2860
P304
P356
10.1177/1073858404270899
P577
2005-04-01T00:00:00Z